Transaction strengthens Leafly’s position as a leading online cannabis discovery marketplace SEATTLE & NEW YORK, February 04, 2022–(BUSINESS WIRE)–Leafly Holdings Inc. (“Leafly” or the “Company”), a leading online cannabis discovery marketplace and resource for cannabis consumers, and Merida Merger Corp. I (NASDAQ: MCMJ) (“Merida”), a special purpose acquisition company... Read more
Ryan Allway January 24th, 2022 SRM Entertainment to raise up to $10 million and seek listing on NasdaqCreates a “Pure Play” Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier Pharmaceuticals JUPITER, FL / ACCESSWIRE / January 24, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it... Read more
SciSparc Provides Updates Upon Conclusion of 2021
December 29, 2021
Ryan Allway December 29th, 2021 TEL AVIV, Israel, Dec. 29, 2021 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today provides updates regarding its activities in 2021. SciSparc Ltd. Logo... Read more
SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market
CBD December 20, 2021
Ryan Allway December 20th, 2021 TEL AVIV, Israel, Dec. 20, 2021 /PRNewswire/ — SciSparc Ltd. (OTCQB: SPRCF) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced that its ordinary shares have been approved for listing... Read more
High Tide Announces At-The-Market Facility of up to CAD$40,000,000 for Strategic Initiatives
December 6, 2021
The Company will determine, at its sole discretion, the date, minimum price and maximum number of Common Shares to be sold under the ATM Program. The Common Shares will be distributed at the market prices prevailing at the time of each sale, at prices relating to such prevailing market... Read more
Ryan Allway August 5th, 2021 BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved for uplisting to the Nasdaq... Read more
New CBD Trials Point the Way for Enveric, MagicMed
CBD July 30, 2021
Ryan Allway July 30th, 2021 Psychedelics, Top Story As the cannabis industry strives to gain widespread acceptance in the mainstream, scientific studies into the potential benefits of the plant and its active ingredients play a key role in reaching that goal. There are currently very few approved pharmaceutical drug... Read more
Ryan Allway May 28th, 2021 Uncategorized High Tide becomes the first major publicly traded cannabis retailer to announce it has been approved to trade on Nasdaq. High Tide shares expected to begin trading on Nasdaq on June 2nd, 2021 High Tide has received approval from Nasdaq to list its... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
“Today’s news represents a significant milestone towards High Tide becoming the first major cannabis retailer anywhere in the world to be listed on Nasdaq, making our shares more accessible to a larger audience of both retail and institutional investors, and increasing our appeal to potential M&A targets,” said Raj... Read more
